Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



High-Dose Trivalent Influenza Vaccine or Standard-Dose Quadrivalent Inactivated Influenza Vaccine in Treating Adult Stem Cell Transplant Recipients

This randomized phase II studies the side effects of high-dose trivalent influenza vaccine or standard-dose quadrivalent inactivated influenza and how well they work in treating adult patients undergoing stem cell transplant. Season influenza can cause more severe infections in patients who have had a stem cell transplant since their immune system doesn’t work as well. Influenza vaccine may provide better protection against flu in adults.
Not Available
II
Halasa, Natasha
NCT03179761
VICCBMT1733

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: